A new trading day began on Friday, with Protara Therapeutics Inc (NASDAQ: TARA) stock price up 12.73% from the previous day of trading, before settling in for the closing price of $6.44. TARA’s price has ranged from $2.28 to $10.48 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 55.31% over the last five years. Meanwhile, its annual earnings per share averaged 40.17%. With a float of $34.50 million, this company’s outstanding shares have now reached $38.59 million.
Protara Therapeutics Inc (TARA) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Protara Therapeutics Inc is 10.58%, while institutional ownership is 61.60%. The most recent insider transaction that took place on May 14 ’25, was worth 63,800. In this transaction Director of this company bought 20,000 shares at a rate of $3.19, taking the stock ownership to the 51,000 shares. Before that another transaction happened on Mar 26 ’25, when Company’s Chf Scientific Operations Off sold 21,224 for $4.53, making the entire transaction worth $96,145. This insider now owns 98,861 shares in total.
Protara Therapeutics Inc (TARA) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.43 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.17% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.56% during the next five years compared to 55.31% growth over the previous five years of trading.
Protara Therapeutics Inc (NASDAQ: TARA) Trading Performance Indicators
Here are Protara Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 13.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.44, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.39 in one year’s time.
Technical Analysis of Protara Therapeutics Inc (TARA)
Analysing the last 5-days average volume posted by the [Protara Therapeutics Inc, TARA], we can find that recorded value of 1.26 million was better than the volume posted last year of 0.39 million. As of the previous 9 days, the stock’s Stochastic %D was 87.41%.
During the past 100 days, Protara Therapeutics Inc’s (TARA) raw stochastic average was set at 93.11%, which indicates a significant increase from 90.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.57 in the past 14 days, which was higher than the 0.28 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.90, while its 200-day Moving Average is $3.84. Now, the first resistance to watch is $7.75. This is followed by the second major resistance level at $8.25. The third major resistance level sits at $8.90. If the price goes on to break the first support level at $6.60, it is likely to go to the next support level at $5.95. Should the price break the second support level, the third support level stands at $5.45.
Protara Therapeutics Inc (NASDAQ: TARA) Key Stats
With a market capitalization of 280.14 million, the company has a total of 38,587K Shares Outstanding. Currently, annual sales are 0 K while annual income is -44,600 K. The company’s previous quarter sales were 0 K while its latest quarter income was -13,260 K.
